|

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

RECRUITINGSponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Actively Recruiting
SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain
Started2026-02-19
Est. completion2056-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07703683

Summary

Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population. .

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Metabolic or endocrine disease

Exclusion Criteria:

* Known myopathy
* Systemic steroid use (\> 1 mg/kg hydrocortisone) or exogenous Cushing's syndrome
* Psychological, family, sociological or geographical conditions that could potentially limit compliance with the study protocol
* History of cancer within the five years prior to the study or Cushing's syndrome due to ACTH-secreting tumor

Conditions7

Cushing SyndromeDiabetesEndocrine DiseasesMetabolic DiseasesObesity & OverweightSarcopeniaSarcopenic Obesity

Interventions1

GLP-1 Receptor Agonists

Related trials

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.